Downs DA - Search Results

1

1,3-Dialkyl-4-(iminoarylmethyl)-1H-pyrazol-5-ols. A series of novel potential antipsychotic agents.

Wise LD, Butler DE, DeWald HA, Lustgarten DM, Pattison IC, Schweiss DN, Coughenour LL, Downs DA, Heffner TG, Pugsley TA. Wise LD, et al. Among authors: downs da. J Med Chem. 1987 Oct;30(10):1807-12. doi: 10.1021/jm00393a021. J Med Chem. 1987. PMID: 2888897

2

CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.

Heffner TG, Downs DA, Meltzer LT, Wiley JN, Williams AE. Heffner TG, et al. Among authors: downs da. J Pharmacol Exp Ther. 1989 Oct;251(1):105-12. J Pharmacol Exp Ther. 1989. PMID: 2571712

3

Examination of a series of 8-[3-[bis(4-fluorophenyl)amino]propyl]-1-aryl-1,3,8- triazaspiro[4.5]decan-4-ones as potential antipsychotic agents.

Wise LD, Pattison IC, Butler DE, DeWald HA, Lewis EP, Lobbestael SJ, Tecle H, Coughenour LL, Downs DA, Poschel BP. Wise LD, et al. Among authors: downs da. J Med Chem. 1985 Dec;28(12):1811-7. doi: 10.1021/jm00150a011. J Med Chem. 1985. PMID: 2866248

4

(5-Amino-1,3-dimethyl-1H-pyrazol-4-yl)(2-fluorophenyl)methanones . A series of novel potential antipsychotic agents.

Wise LD, Butler DE, DeWald HA, Lustgarten D, Coughenour LL, Downs DA, Heffner TG, Pugsley TA. Wise LD, et al. Among authors: downs da. J Med Chem. 1986 Sep;29(9):1628-37. doi: 10.1021/jm00159a011. J Med Chem. 1986. PMID: 2875184

5

N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity.

Bridges AJ, Moos WH, Szotek DL, Trivedi BK, Bristol JA, Heffner TG, Bruns RF, Downs DA. Bridges AJ, et al. Among authors: downs da. J Med Chem. 1987 Oct;30(10):1709-11. doi: 10.1021/jm00393a003. J Med Chem. 1987. PMID: 2888894 No abstract available.

6

Synthesis and potential antipsychotic activity of 1H-imidazo[1,2-c]pyrazolo[3,4-e]pyrimidines.

DeWald HA, Beeson NW, Hershenson FM, Wise LD, Downs DA, Heffner TG, Coughenour LL, Pugsley TA. DeWald HA, et al. Among authors: downs da. J Med Chem. 1988 Feb;31(2):454-61. doi: 10.1021/jm00397a032. J Med Chem. 1988. PMID: 2892936

7

Comparison of the behavioral effects of adenosine agonists and dopamine antagonists in mice.

Heffner TG, Wiley JN, Williams AE, Bruns RF, Coughenour LL, Downs DA. Heffner TG, et al. Among authors: downs da. Psychopharmacology (Berl). 1989;98(1):31-7. doi: 10.1007/BF00442002. Psychopharmacology (Berl). 1989. PMID: 2498959

8

Pharmacologic activity of CI-977, a selective kappa opioid agonist, in rhesus monkeys.

Davis RE, Callahan MJ, Dickerson M, Downs DA. Davis RE, et al. Among authors: downs da. J Pharmacol Exp Ther. 1992 Jun;261(3):1044-9. J Pharmacol Exp Ther. 1992. PMID: 1318369

9

Lack of antagonism by naloxone of the analgesic and locomotor stimulant actions of ketamine.

Wiley JN, Downs DA. Wiley JN, et al. Among authors: downs da. Life Sci. 1982 Sep 13;31(11):1071-5. doi: 10.1016/0024-3205(82)90079-0. Life Sci. 1982. PMID: 7144425 No abstract available.

10

Naloxone-precipitated jumping in mice pretreated with acute injections of opioids.

Wiley JN, Downs DA. Wiley JN, et al. Among authors: downs da. Life Sci. 1979 Aug 27;25(9):797-801. doi: 10.1016/0024-3205(79)90525-3. Life Sci. 1979. PMID: 491858 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters